Ocular Therapeutix, Inc. Announces Positive Topline Phase 1 Data for AXPAXLI? in Diabetic Retinopathy

Ocular Therapeutix, Inc. announced positive topline results from the Phase 1 HELIOS study evaluating AXPAXLI versus a sham control in patients with moderately severe to severe non-proliferative...

Related Keywords

,Ocular Therapeutix Inc ,Ocular Therapeutix ,Topline Phase ,Efficacy Results ,Diabetic Retinopathy Severity Scale ,Next Steps ,